Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca

This study has been terminated.
(Slow accrual)
Information provided by (Responsible Party):
Masonic Cancer Center, University of Minnesota Identifier:
First received: November 1, 2008
Last updated: April 10, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2015
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)